Article
The pharmocogenomics of warfarin: closing in on personalized medicine.
Molecular interventions - 1 Aug 2006
Rettie Allan E, Tai Guoying
Abstract excerpt
Warfarin, a coumarin anticoagulant, is used worldwide for the treatment and prevention of thromboembolic disease. Warfarin therapy, however, can be difficult to manage because of the drug's narrow therapeutic index and the wide interindividual variability in patient response. It is now clear that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
